---
figid: PMC9353402__etm-24-03-11513-g04
pmcid: PMC9353402
image_filename: etm-24-03-11513-g04.jpg
figure_link: /pmc/articles/PMC9353402/figure/f5-ETM-24-3-11513/
number: Figure 5
figure_title: ''
caption: Detection of the myocardial inflammatory response indicators MPO and ROS
  by enzyme-linked immunosorbent assay (ELISA) and Chemiluminescence. N group, n=20;
  LINS group, n=13; LIIL group, n=10; LIILR group, n=18. N group, normal control group;
  LINS group, LAD ligation with an injection of normal saline group; LIIL group, LAD
  ligation with an injection of IL-6 recombinant protein group; LIILR group, LAD ligation
  with injection of IL-6 receptor inhibitor group; ROS, reactive oxygen species; MPO,
  myeloperoxidase.
article_title: IL-6 inhibitors effectively reverse post-infarction cardiac injury
  and ischemic myocardial remodeling via the TGF-β1/Smad3 signaling pathway.
citation: Jiahong Wang, et al. Exp Ther Med. 2022 Sep;24(3):576.
year: '2022'

doi: 10.3892/etm.2022.11513
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- interleukin 6
- interleukin 6 inhibitor
- myocardial infarction
- rejuvenation
- TGFβ1/Smad3
- ventricular remodeling

---
